TaiRx Revenue

In the year 2024, TaiRx had annual revenue of 8.22M TWD with 61.79% growth. TaiRx had revenue of 7.96M in the half year ending December 31, 2024, with 26.20% growth.

Revenue

8.22M

Revenue Growth

+61.79%

P/S Ratio

330.51

Revenue / Employee

n/a

Employees

n/a

Market Cap

2.72B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	8.22M	3.14M	61.79%
Dec 31, 2023	5.08M	-1.84M	-26.59%
Dec 31, 2022	6.92M	1.78M	34.66%
Dec 31, 2021	5.14M	1.78M	53.05%
Dec 31, 2020	3.36M	203.00K	6.43%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
PharmaEssentia	11.34B
Caliway Biopharmaceuticals	40.47M
Bora Pharmaceuticals Co., LTD.	20.87B
Lotus Pharmaceutical	19.12B
Polaris Group	87.67M
Lumosa Therapeutics	43.59M
Center Laboratories	1.63B
Oneness Biotech	117.33M

Revenue Rankings